Emerging therapies and treatment strategies in pulmonary arterial hypertension
Pulmonary hypertension is a very heterogeneous condition, with pulmonary arterial hypertension being the quintessential diagnosis. Paul Forfia summarises the available treatment options and the new strategy of combination therapy. Adjusting medication based on monitoring right ventricular size and function is a new and important treatment goal. He also elaborates on management options for other forms of pulmonary hypertension.
Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA
Paul R. Forfia, MD - Director, Pulmonary Hypertension/Right Heart Failure and Pulmonary Thromboendarterectomy Program, Associate Professor of Medicine, Temple University Hospital, Philadelphia, PA, USA
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: